Douglas Carr
SVP Finance & Operations at Century Therapeutics, Inc. (IPSC)
Douglas Carr has filed 29 insider reports with the SEC since January 2022, as SVP Finance & Operations at Century Therapeutics, Inc. (IPSC). In the last 12 months Douglas Carr sold $28.8K of stock on the open market. In the latest filing, on November 5, 2026, Douglas Carr sold 266 shares of Century Therapeutics, Inc. (IPSC) for $404 at an average of $1.52.
- Filings
- 29
- Companies
- 1
- Bought on market
- None
- Sold on market
- $40.2K
Companies where Douglas Carr is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| SVP Finance & Operations | 502,641 | $40.2K | $1.165 | Nov 5, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Nov 3, 2026-$404IPSCSVP Finance & Operations Carr Douglas sold $404 worth of shares (266 units at $1.52), decreasing direct ownership by 0.05% to 502,641 units (for withholding tax)Form 4Open-market sale
- Sep 14, 2026-$3,200IPSCSVP Finance & Operations Carr Douglas sold $3,200 worth of shares (1,658 units at $1.93), decreasing direct ownership by 0.33% to 502,907 units to satisfy withholding obligationForm 4Open-market sale
- Sep 8, 2026-$521IPSCSVP Finance & Operations Carr Douglas sold $521 worth of shares (254 units at $2.05), decreasing direct ownership by 0.05% to 504,565 units to cover withholding taxForm 4Open-market sale
- Aug 3, 2026-$544IPSCSVP Finance & Operations Carr Douglas sold $544 worth of shares (275 units at $1.98), decreasing direct ownership by 0.05% to 504,819 units (withholding obligation)Form 4Open-market sale
- Jun 12, 2026-$3,692IPSCSVP Finance & Operations Carr Douglas sold $3,692 worth of shares (1,654 units at $2.23), decreasing direct ownership by 0.33% to 505,094 units (tax liability)Form 4Open-market sale
- Jun 8, 2026-$526IPSCSVP Finance & Operations Carr Douglas sold $526 worth of shares (249 units at $2.11), decreasing direct ownership by 0.05% to 506,748 units (withholding obligation)Form 4Open-market sale
- May 4, 2026-$618IPSCSVP Finance & Operations Carr Douglas sold $618 worth of shares (264 units at $2.34), decreasing direct ownership by 0.05% to 506,997 units (for withholding tax)Form 4Open-market sale
- Mar 12, 2026-$18KIPSCSVP Finance & Operations Carr Douglas sold $17,953 worth of shares (7,043 units at $2.55), decreasing direct ownership by 1% to 507,261 unitsForm 4Open-market sale
- Mar 9, 2026-$626IPSCSVP Finance & Operations Carr Douglas sold $626 worth of shares (247 units at $2.54), decreasing direct ownership by 0.05% to 514,304 unitsForm 4Open-market sale
- Feb 3, 2026-$589IPSCSVP Finance & Operations Carr Douglas sold $589 worth of shares (323 units at $1.82), decreasing direct ownership by 0.06% to 514,551 unitsForm 4Open-market sale
- Feb 2, 2026IPSCSVP Finance & Operations Carr Douglas was granted 110,000 shares, increasing direct ownership by 27% to 514,874 unitsForm 4Grant or award
- Dec 8, 2025-$137IPSCSVP Finance & Operations Carr Douglas sold $137 worth of shares (257 units at $0.53), decreasing direct ownership by 0.06% to 404,874 unitsForm 4Open-market sale
- Nov 3, 2025-$171IPSCSVP Finance & Operations Carr Douglas sold $171 worth of shares (292 units at $0.59), decreasing direct ownership by 0.07% to 405,131 unitsForm 4Open-market sale
- Sep 8, 2025-$132IPSCSVP Finance & Operations Carr Douglas sold $132 worth of shares (263 units at $0.50), decreasing direct ownership by 0.06% to 405,423 unitsForm 4Open-market sale
- Aug 4, 2025-$158IPSCSVP Finance & Operations Carr Douglas sold $158 worth of shares (296 units at $0.53), decreasing direct ownership by 0.07% to 405,686 unitsForm 4Open-market sale
- Jun 9, 2025-$3,050IPSCSVP Finance & Operations Carr Douglas sold $3,050 worth of shares (4,904 units at $0.62), decreasing direct ownership by 1% to 405,982 unitsForm 4Open-market sale
- May 5, 2025-$162IPSCSVP Finance & Operations Carr Douglas sold $162 worth of shares (295 units at $0.55), decreasing direct ownership by 0.07% to 410,886 unitsForm 4Open-market sale
- Mar 11, 2025-$763IPSCSVP Finance & Operations Carr Douglas sold $763 worth of shares (1,240 units at $0.61) and was granted 95,625 shares, increasing direct ownership by 30% to 411,181 unitsForm 4Grant or awardOpen-market sale
- Feb 3, 2025-$274IPSCSVP Finance & Operations Carr Douglas sold $274 worth of shares (351 units at $0.78), decreasing direct ownership by 0.11% to 316,796 unitsForm 4Open-market sale
- Nov 4, 2024-$347IPSCSVP Finance & Operations Carr Douglas covered exercise/tax liability with 16,611 shares and sold $347 worth of shares (283 units at $1.23), decreasing direct ownership by 5% to 317,147 unitsForm 4Shares withheld for taxes or exercise priceOpen-market sale
- Aug 5, 2024-$528IPSCSVP Finance & Operations Carr Douglas sold $528 worth of shares (289 units at $1.83), decreasing direct ownership by 0.09% to 334,041 unitsForm 4Open-market sale
- Jun 7, 2024IPSCSVP Finance & Operations Carr Douglas was granted 17,007 shares, increasing direct ownership by 5% to 334,330 unitsForm 4Grant or award
- May 3, 2024-$798IPSCCarr Douglas sold $798 worth of shares (257 units at $3.11), decreasing direct ownership by 0.08% to 317,323 unitsForm 4Open-market sale
- Mar 7, 2024IPSCCarr Douglas was granted 14,000 shares, increasing direct ownership by 5% to 317,580 unitsForm 4Grant or award
- Feb 6, 2024-$4,969IPSCCarr Douglas sold $4,969 worth of shares (1,200 units at $4.14), decreasing direct ownership by 0.39% to 303,580 unitsForm 4Open-market sale
- Nov 1, 2023IPSCCarr Douglas covered exercise/tax liability with 16,611 shares, decreasing direct ownership by 5% to 304,780 unitsForm 4Shares withheld for taxes or exercise price
- May 15, 2023IPSCSEC Form 4 filed by Carr DouglasForm 4Grant or award
- Feb 2, 2023IPSCSEC Form 4: Carr Douglas was granted 15,000 shares, increasing direct ownership by 8% to 200,545 unitsForm 4Grant or award
- Jan 25, 2022IPSCSEC Form 4 filed by Carr DouglasForm 4Grant or award
Compare Douglas Carr with
- Douglas Carr vs Brent Pfeiffenberger1 shared
- Douglas Carr vs Gregory Russotti1 shared
- Douglas Carr vs Joseph Truitt1 shared
- Douglas Carr vs Chad Cowan1 shared
- Douglas Carr vs Alessandro Riva1 shared
- Douglas Carr vs Daphne Quimi1 shared
Other insiders at the same companies
- Brent PfeiffenbergerIPSC
- Gregory RussottiIPSC
- Joseph TruittIPSC
- Chad CowanIPSC
- Alessandro RivaIPSC
- Daphne QuimiIPSC
- Martin Patrick MurphyIPSC
- Han Myung LeeIPSC
- Kimberly BlackwellIPSC
- Joseph JimenezIPSC
- Rizzuto CarloIPSC
- Cynthia M ButittaIPSC
- Timothy P WalbertIPSC
- Adrienne FaridIPSC
- Morgan ConnIPSC
Questions about Douglas Carr
- What is Douglas Carr's role at Century Therapeutics, Inc.?
- Douglas Carr reports to the SEC as SVP Finance & Operations at Century Therapeutics, Inc. (IPSC), according to the latest filing on November 5, 2026.
- How many shares does Douglas Carr own?
- After the latest filing that states it, Douglas Carr directly owned 502,641 shares of Century Therapeutics, Inc. (IPSC). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Douglas Carr bought or sold stock recently?
- The most recent open-market sale was on November 3, 2026: sold 266 shares of Century Therapeutics, Inc. (IPSC) for $404 at an average of $1.52.
- How do I get alerts when Douglas Carr files?
- Follow Douglas Carr on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Douglas Carr filed 3 times in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Douglas Carr (SEC CIK 0001867173). Totals count each trade once, skipping amendments whose original is on file, from Jan 27, 2022 on. View on SEC EDGAR · Get this as JSON